Literature DB >> 12815653

Clinical features and neuroimaging of PARK7-linked parkinsonism.

Marieke Dekker1, Vincenzo Bonifati, John van Swieten, Nico Leenders, Robert-Jan Galjaard, Pieter Snijders, Marten Horstink, Peter Heutink, Ben Oostra, Cornelia van Duijn.   

Abstract

We recently reported linkage to chromosome 1p36 (the PARK7-locus) in a family with early-onset parkinsonism. Linkage to this locus has since been confirmed in an independent data set. We describe clinical and neuroimaging features of the 4 patients in the original PARK7-linked kindred. Age at onset of parkinsonism varied from 27 to 40 years. Clinical progression was slow, and response to dopaminergic therapy good. The clinical spectrum ranged from mild hypokinesia and rigidity, to severe parkinsonism with levodopa-induced dyskinesias and motor fluctuation. Three of four patients with PARK7-linked parkinsonism exhibited psychiatric disturbances. Structural neuroimaging was unremarkable, but functional imaging of the brain, carried out in 3 patients, showed significant evidence for a presynaptic dopamine deficit, and assessment of cerebral glucose metabolism, as carried out in 1 patient, showed possible cerebellar involvement. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815653     DOI: 10.1002/mds.10422

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

Review 1.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 2.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Authors:  Thorfinn T Riday; Elyse C Dankoski; Michael C Krouse; Eric W Fish; Paul L Walsh; Ji Eun Han; Clyde W Hodge; R Mark Wightman; Benjamin D Philpot; C J Malanga
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

4.  Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats.

Authors:  Jianjun Sun; Evguenia Kouranova; Xiaoxia Cui; Robert H Mach; Jinbin Xu
Journal:  Neurosci Lett       Date:  2013-10-22       Impact factor: 3.046

5.  Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

Authors:  Alexandra Beilina; Marcel Van Der Brug; Rili Ahmad; Sashi Kesavapany; David W Miller; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

6.  Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.

Authors:  Tohru Kitada; Youren Tong; Clement A Gautier; Jie Shen
Journal:  J Neurochem       Date:  2009-08-19       Impact factor: 5.372

7.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

8.  Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.

Authors:  J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2009-10-07       Impact factor: 4.891

Review 9.  Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.

Authors:  Vincenzo Bonifati; Ben A Oostra; Peter Heutink
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

Review 10.  Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician.

Authors:  Una-Marie Sheerin; Henry Houlden; Nicholas W Wood
Journal:  Mov Disord Clin Pract       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.